AAAAAA

   
Results: 1-25 | 26-36
Results: 1-25/36
REGISTER STUDY FOR THE TREATMENT OF BRAIN METASTASES OF MALIGNANT TESTICULAR-TUMORS
Authors: HARTMANN JT ALBERS P CLEMM C SOUCHON R WEISSBACH L BAMBERG M BOKEMEYER C
Citation: Jt. Hartmann et al., REGISTER STUDY FOR THE TREATMENT OF BRAIN METASTASES OF MALIGNANT TESTICULAR-TUMORS, Onkologie, 21(3), 1998, pp. 262-263
STONE FORMATION AFTER PYELOPLASTY THROUGH THE SUTURE MATERIAL
Authors: LOCK UC VONPOKRZYWNITZKI W WEISSBACH L
Citation: Uc. Lock et al., STONE FORMATION AFTER PYELOPLASTY THROUGH THE SUTURE MATERIAL, Der Urologe, 37(5), 1998, pp. 522-525
REGISTER STUDY OF PATIENTS WITH CNS METASTASES FROM TESTICULAR GERM-CELL CANCER
Authors: HARTMANN JT ALBERS P CLEMM C SOUCHON R WEISSBACH L BAMBERG M BOKEMEYER C
Citation: Jt. Hartmann et al., REGISTER STUDY OF PATIENTS WITH CNS METASTASES FROM TESTICULAR GERM-CELL CANCER, Strahlentherapie und Onkologie, 174(6), 1998, pp. 339-339
BINDING OF MYOSIN ESSENTIAL LIGHT-CHAIN TO THE CYTOSKELETON-ASSOCIATED PROTEIN IQGAP1
Authors: WEISSBACH L BERNARDS A HERION DW
Citation: L. Weissbach et al., BINDING OF MYOSIN ESSENTIAL LIGHT-CHAIN TO THE CYTOSKELETON-ASSOCIATED PROTEIN IQGAP1, Biochemical and biophysical research communications (Print), 251(1), 1998, pp. 269-276
DETECTION OF AN INTERLEUKIN-1 INTRACELLULAR RECEPTOR ANTAGONIST MESSENGER-RNA VARIANT
Authors: WEISSBACH L TRAN K COLQUHOUN SA CHAMPLIAUD MF TOWLE CA
Citation: L. Weissbach et al., DETECTION OF AN INTERLEUKIN-1 INTRACELLULAR RECEPTOR ANTAGONIST MESSENGER-RNA VARIANT, Biochemical and biophysical research communications, 244(1), 1998, pp. 91-95
LESSONS FROM PROSPECTIVE MULTICENTER STUDY ON SEMINOMAS
Authors: WEISSBACH L BUSSARMAAJZ R LOHRS U MANN K SCHUBERT G
Citation: L. Weissbach et al., LESSONS FROM PROSPECTIVE MULTICENTER STUDY ON SEMINOMAS, European journal of cancer, 33, 1997, pp. 155-155
INTERDISCIPLINARY CONSENSUS CONFERENCE ON DIAGNOSTICS AND THERAPY OF TESTICULAR CARCINOMAS
Authors: SCHMOLL HJ BAMBERG M WEISSBACH L
Citation: Hj. Schmoll et al., INTERDISCIPLINARY CONSENSUS CONFERENCE ON DIAGNOSTICS AND THERAPY OF TESTICULAR CARCINOMAS, Onkologie, 20(2), 1997, pp. 164-170
HIGH-DOSE CHEMOTHERAPY AND REINFUSION OF HEMATOPOIETIC STEM-CELLS ADVANCED GERM-CELL TUMORS WITH POOR-PROGNOSIS IN 1996
Authors: PONT J HOLTL W WEISSBACH L BEYER J SIEGERT W
Citation: J. Pont et al., HIGH-DOSE CHEMOTHERAPY AND REINFUSION OF HEMATOPOIETIC STEM-CELLS ADVANCED GERM-CELL TUMORS WITH POOR-PROGNOSIS IN 1996, Der Urologe, 36(6), 1997, pp. 561-564
INTERDISCIPLINARY CONSENSUS CONFERENCE ON DIAGNOSIS AND TREATMENT OF TESTICULAR-TUMORS
Authors: WEISSBACH L BAMBERG M SCHMOLL HJ
Citation: L. Weissbach et al., INTERDISCIPLINARY CONSENSUS CONFERENCE ON DIAGNOSIS AND TREATMENT OF TESTICULAR-TUMORS, Der Urologe, 36(4), 1997, pp. 362-368
THE VALUE OF TUMOR-MARKERS IN TESTICULAR SEMINOMAS - RESULTS OF A PROSPECTIVE MULTICENTER STUDY
Authors: WEISSBACH L BUSSARMAATZ R MANN K
Citation: L. Weissbach et al., THE VALUE OF TUMOR-MARKERS IN TESTICULAR SEMINOMAS - RESULTS OF A PROSPECTIVE MULTICENTER STUDY, European urology, 32(1), 1997, pp. 16-22
ELEVATED HUMAN CHORIONIC-GONADOTROPIN CONCENTRATIONS IN THE TESTICULAR VEIN AND IN PERIPHERAL VENOUS-BLOOD IN SEMINOMA PATIENTS - AN ANALYSIS OF VARIOUS PARAMETERS
Authors: HARTMANN M POTTEK T BUSSARMAATZ R WEISSBACH L
Citation: M. Hartmann et al., ELEVATED HUMAN CHORIONIC-GONADOTROPIN CONCENTRATIONS IN THE TESTICULAR VEIN AND IN PERIPHERAL VENOUS-BLOOD IN SEMINOMA PATIENTS - AN ANALYSIS OF VARIOUS PARAMETERS, European urology, 31(4), 1997, pp. 408-413
SIGNIFICANCE OF MARKER STATUS IN CYSTS OF ADVANCED TESTICULAR GERM-CELL TUMORS AFTER CHEMOTHERAPY
Authors: HOLZEL C WEISSBACH L MANN K
Citation: C. Holzel et al., SIGNIFICANCE OF MARKER STATUS IN CYSTS OF ADVANCED TESTICULAR GERM-CELL TUMORS AFTER CHEMOTHERAPY, Aktuelle Urologie, 28(5), 1997, pp. 260-262
A RANDOMIZED TRIAL OF CISPLATIN, ETOPOSIDE AND BLEOMYCIN (PEB) VERSUSCARBOPLATIN, ETOPOSIDE AND BLEOMYCIN (CEB) FOR PATIENTS WITH GOOD-RISK METASTATIC NONSEMINOMATOUS GERM-CELL TUMORS
Authors: BOKEMEYER C KOHRMANN O TISCHLER J WEISSBACH L RATH U HAUPT A SCHOFFSKI P HARSTRICK A SCHMOLL HJ
Citation: C. Bokemeyer et al., A RANDOMIZED TRIAL OF CISPLATIN, ETOPOSIDE AND BLEOMYCIN (PEB) VERSUSCARBOPLATIN, ETOPOSIDE AND BLEOMYCIN (CEB) FOR PATIENTS WITH GOOD-RISK METASTATIC NONSEMINOMATOUS GERM-CELL TUMORS, Annals of oncology, 7(10), 1996, pp. 1015-1021
PHASE-II STUDY OF PACLITAXEL IN PATIENTS WITH RELAPSED OR CISPLATIN-REFRACTORY TESTICULAR CANCER
Authors: BOKEMEYER C BEYER J METZNER B RUTHER U HARSTRICK A WEISSBACH L KOHRMANN U VERBEEK W SCHMOLL HJ
Citation: C. Bokemeyer et al., PHASE-II STUDY OF PACLITAXEL IN PATIENTS WITH RELAPSED OR CISPLATIN-REFRACTORY TESTICULAR CANCER, Annals of oncology, 7(1), 1996, pp. 31-34
GEMCITABINE - A PHASE-II STUDY IN PATIENTS WITH ADVANCED RENAL-CANCER
Authors: DEMULDER PHM WEISSBACH L JAKSE G OSIEKA R BLATTER J
Citation: Phm. Demulder et al., GEMCITABINE - A PHASE-II STUDY IN PATIENTS WITH ADVANCED RENAL-CANCER, Cancer chemotherapy and pharmacology, 37(5), 1996, pp. 491-495
PATHOGENESIS, DIAGNOSIS AND THERAPY OF TE STICULAR-TUMORS
Authors: WEISSBACH L BUSSARMAATZ R
Citation: L. Weissbach et R. Bussarmaatz, PATHOGENESIS, DIAGNOSIS AND THERAPY OF TE STICULAR-TUMORS, Der Urologe, 35(2), 1996, pp. 163-172
THE RAS GTPASE-ACTIVATING-PROTEIN-RELATED HUMAN PROTEIN IQGAP2 HARBORS A POTENTIAL ACTIN-BINDING DOMAIN AND INTERACTS WITH CALMODULIN AND RHO FAMILY GTPASES
Authors: BRILL S LI SH LYMAN CW CHURCH DM WASMUTH JJ WEISSBACH L BERNARDS A SNIJDERS AJ
Citation: S. Brill et al., THE RAS GTPASE-ACTIVATING-PROTEIN-RELATED HUMAN PROTEIN IQGAP2 HARBORS A POTENTIAL ACTIN-BINDING DOMAIN AND INTERACTS WITH CALMODULIN AND RHO FAMILY GTPASES, Molecular and cellular biology, 16(9), 1996, pp. 4869-4878
EXPERIMENTAL AND CLINICAL EFFICACY OF 2',2'-DIFLUORODEOXYCYTIDINE (GEMCITABINE) AGAINST RENAL-CELL CARCINOMA
Authors: ROHDE D DEMULDER PHM WEISSBACH L OSIEKA R BLATTER J JAKSE G
Citation: D. Rohde et al., EXPERIMENTAL AND CLINICAL EFFICACY OF 2',2'-DIFLUORODEOXYCYTIDINE (GEMCITABINE) AGAINST RENAL-CELL CARCINOMA, Oncology, 53(6), 1996, pp. 476-481
A RANDOMIZED MULTICENTER TRIAL OF ADJUVANT THERAPY IN SUPERFICIAL BLADDER-CANCER - TRANSURETHRAL RESECTION ONLY VERSUS TRANSURETHRAL RESECTION PLUS MITOMYCIN-C VERSUS TRANSURETHRAL RESECTION PLUS BACILLUS-CALMETTE-GUERIN
Authors: KREGE S GIANI G MEYER R OTTO T RUBBEN H NOLL F JAKSE G MELCHIOR HJ WEISSBACH L TERHORST B LENZ P FAUL P SOMMERKAMP H KOPPER B HAUTMANN R KNEBEL L EISENBERGER F SCHAFFNER W
Citation: S. Krege et al., A RANDOMIZED MULTICENTER TRIAL OF ADJUVANT THERAPY IN SUPERFICIAL BLADDER-CANCER - TRANSURETHRAL RESECTION ONLY VERSUS TRANSURETHRAL RESECTION PLUS MITOMYCIN-C VERSUS TRANSURETHRAL RESECTION PLUS BACILLUS-CALMETTE-GUERIN, The Journal of urology, 156(3), 1996, pp. 962-966
EFFICACY AND TOLERABILITY OF CASODEX IN PATIENTS WITH ADVANCED PROSTATE-CANCER
Authors: LUNGLMAYR G ALFTHAN O ALTWEIN JE BLACKLEDGE G BLACKLOCK NJ BONO A BOUFFIOUX C CHANNER K DEBRUYNE F DENIS L DISILVERIO F GRASSET D HAEFLINGER JM HARLAND S HEIJBROEK RP HOISAETER PA IVERSEN P JAEGER N KEUPPENS F KHOE GS KLARSKOV P KONTTURI M KUBER W KUMS JJM LARDENOYE JG LEDUC A LUNGLMAYR G MOEHRING K NEWLING D PAVONEMACALUSO M PERMI J RASMUSSEN F ROSSETTI SR SANDER S SARRAMON JP SMITH PH TVETER K TYRRELL CJ USAI E VALLANCIEN GMB VANCANGH PJ VARENHORST E WEISSBACH L WHELAN P WILLIAMS JL ZALCBERG J ZATTONI F DAWES PM
Citation: G. Lunglmayr et al., EFFICACY AND TOLERABILITY OF CASODEX IN PATIENTS WITH ADVANCED PROSTATE-CANCER, Anti-cancer drugs, 6(4), 1995, pp. 508-513
ORGAN-PRESERVING SURGERY OF MALIGNANT GERM-CELL TUMORS
Authors: WEISSBACH L
Citation: L. Weissbach, ORGAN-PRESERVING SURGERY OF MALIGNANT GERM-CELL TUMORS, The Journal of urology, 153(1), 1995, pp. 90-93
SCREENING, DIAGNOSIS AND THERAPY OF TESTI CULAR INTRAEPITHELIAL NEOPLASIA (TIN) - COMMENT
Authors: WEISSBACH L
Citation: L. Weissbach, SCREENING, DIAGNOSIS AND THERAPY OF TESTI CULAR INTRAEPITHELIAL NEOPLASIA (TIN) - COMMENT, Aktuelle Urologie, 26(3), 1995, pp. 180-180
CAN RISK-FACTORS BE DECISIVE FOR THE CHOI CE OF TREATMENT IN CLINICALSTAGE-I OF NONSEMINOMATOUS TESTICULAR-TUMORS
Authors: WEISSBACH L BUSSARMAATZ R
Citation: L. Weissbach et R. Bussarmaatz, CAN RISK-FACTORS BE DECISIVE FOR THE CHOI CE OF TREATMENT IN CLINICALSTAGE-I OF NONSEMINOMATOUS TESTICULAR-TUMORS, Aktuelle Urologie, 26(2), 1995, pp. 79-88
TESTICULAR CANCER-II - EDITORIAL
Authors: WEISSBACH L
Citation: L. Weissbach, TESTICULAR CANCER-II - EDITORIAL, World journal of urology, 12(4), 1994, pp. 169-169
SIZE AND STATUS OF METASTASES AFTER INDUCTIVE CHEMOTHERAPY OF GERM-CELL TURNERS - INDICATION FOR SALVAGE OPERATION
Authors: JAEGER N WEISSBACH L BUSSARMAATZ R
Citation: N. Jaeger et al., SIZE AND STATUS OF METASTASES AFTER INDUCTIVE CHEMOTHERAPY OF GERM-CELL TURNERS - INDICATION FOR SALVAGE OPERATION, World journal of urology, 12(4), 1994, pp. 196-199
Risultati: 1-25 | 26-36